Agriculture · Founded 1986 · www.avtnatural.com · BSE 519105 · NSE AVT NATURAL · ISIN INE488D01021
No Notes Added Yet
Business
AVT Natural Products Ltd. is an Indian company engaged in the processing and export of various plant-based extracts and ingredients. Its core business model revolves around sourcing natural raw materials (like marigold flowers, spices, and tea leaves) from agricultural sources, processing them using advanced extraction technologies, and supplying the resulting natural ingredients to global customers. The company primarily operates as a B2B supplier to industries such as food & beverage, nutraceuticals, animal feed, and cosmetics. It makes money by selling these value-added natural ingredients, which are used for coloring, flavoring, health supplements (e.g., eye health), and other functional purposes.
Revenue Mix
AVT Natural Products operates across three primary product categories:
Marigold Extracts: This segment includes Lutein and Zeaxanthin esters, mainly derived from marigold flowers. These are widely used in nutraceuticals (for eye health supplements) and as natural food coloring agents.
Spice Oleoresins & Extracts: This segment involves extracting concentrated flavors, colors, and aromas from various spices like capsicum, turmeric, black pepper, and ginger. These are utilized in food & beverage, flavors & fragrances, and pharmaceutical industries.
Tea Extracts: This segment focuses on producing instant tea powder and green tea extracts, which are used by beverage manufacturers for ready-to-drink teas and other health-oriented beverages.
Specific revenue contribution percentages for each segment are not consistently disclosed publicly.
Industry
AVT Natural Products operates within the global natural ingredients and plant extracts industry, which is a specialized segment of the broader agriculture and food processing sector. The industry is characterized by a growing demand for natural, clean-label products. While it is somewhat fragmented, quality, consistent supply, and regulatory compliance are crucial differentiators. AVT is an established player with a strong reputation, particularly in marigold extracts, and a diversified portfolio across spice and tea extracts. It competes with both domestic and international natural ingredient manufacturers. Its positioning is that of a reliable, quality-focused B2B supplier with global reach.
MOAT
Backward Integration & Sourcing Expertise: AVT has established strong relationships with farmers and engages in contract farming for key raw materials like marigold, ensuring consistent supply and quality control from source.
Technical Expertise & Scale: Years of experience in extraction technologies and processing at scale provide efficiencies and consistent product quality, which is vital in B2B supply.
Regulatory Compliance & Certifications: The company's adherence to international food safety and quality standards (e.g., ISO, FSSC, Kosher, Halal) creates a barrier to entry and builds trust with global customers who face strict regulatory environments.
Customer Stickiness: For B2B customers, switching suppliers for specialized ingredients can involve re-qualification processes, formulation changes, and supply chain disruptions, creating a degree of switching costs.
Growth Drivers
Increasing Global Demand for Natural Products: The widespread consumer shift towards natural, clean-label, and plant-based ingredients in food, beverages, nutraceuticals, and cosmetics.
Health & Wellness Trend: Growing awareness of health benefits associated with natural ingredients, particularly demand for nutraceuticals like lutein for eye health.
Product Innovation & Diversification: Expanding the portfolio of extracts and ingredients, or developing new applications for existing products.
Emerging Market Opportunities: Penetration into new geographical markets or deeper presence in existing ones for natural ingredients.
Regulatory Tailwinds: Stricter regulations on synthetic additives pushing industries towards natural alternatives.
Risks
Raw Material Price & Supply Volatility: Dependence on agricultural commodities makes the company vulnerable to weather patterns, crop diseases, geopolitical events, and fluctuations in raw material prices.
Regulatory Changes: Stricter or changing food safety and ingredient regulations in key export markets could necessitate costly adaptations or impact product marketability.
Intense Competition: The natural ingredients market is competitive, with both specialized and large diversified players, potentially leading to pricing pressures.
Foreign Exchange Fluctuations: As a significant exporter, adverse movements in major foreign currencies against the Indian Rupee can negatively impact revenues and profitability.
Supply Chain & Logistics Disruptions: Global shipping challenges, trade barriers, or geopolitical events could disrupt raw material imports or finished product exports.
Management & Ownership
AVT Natural Products Ltd. is part of the AVT Group (A.V. Thomas Group), a long-established Indian business conglomerate with a heritage in agricultural commodities like tea, coffee, rubber, and spices. The company is promoter-led, with the promoter group holding a significant ownership stake. The management team typically comprises professionals with considerable experience in the agricultural processing and natural ingredients sector, leveraging the group's long-standing industry knowledge and relationships.
Outlook
AVT Natural Products benefits from strong secular trends towards natural, health-oriented ingredients globally. Its established position, backward integration for key raw materials, and diversified product portfolio across marigold, spice, and tea extracts provide a robust foundation. The growing nutraceuticals and clean-label food industries offer significant tailwinds. However, the company remains susceptible to the inherent volatility of agricultural commodity prices and supply, intense competition from global players, and currency fluctuations, which can impact its margins. Maintaining innovation, regulatory compliance, and efficient supply chain management will be key to sustaining growth and profitability in a dynamic market.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 125 | 105 | 122 | 173 | 157 | 132 | 160 | 194 | 226 | 241 |
| Other Income | 5 | 5 | 5 | 4 | 2 | 4 | 5 | 3 | 1 | 4 |
| Total Income | 130 | 109 | 127 | 177 | 159 | 136 | 166 | 197 | 228 | 246 |
| Total Expenditure | 109 | 97 | 114 | 143 | 132 | 117 | 145 | 171 | 191 | 201 |
| Operating Profit | 20 | 13 | 13 | 34 | 27 | 20 | 20 | 27 | 37 | 44 |
| Interest | 2 | 1 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 15 | 8 | 8 | 28 | 20 | 15 | 16 | 22 | 30 | 39 |
| Provision for Tax | 4 | 2 | 1 | 6 | 5 | 3 | 2 | 4 | 8 | 8 |
| Profit After Tax | 11 | 6 | 6 | 22 | 14 | 12 | 13 | 17 | 22 | 31 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 11 | 6 | 6 | 22 | 14 | 12 | 13 | 17 | 22 | 31 |
| Adjusted Earnings Per Share | 0.7 | 0.4 | 0.4 | 1.4 | 0.9 | 0.8 | 0.9 | 1.1 | 1.4 | 2 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 274 | 311 | 328 | 339 | 396 | 485 | 559 | 582 | 517 | 559 | 713 | 821 |
| Other Income | 2 | 5 | 13 | 4 | 7 | 8 | 10 | 2 | 13 | 13 | 14 | 13 |
| Total Income | 276 | 316 | 341 | 343 | 403 | 494 | 570 | 585 | 530 | 572 | 727 | 837 |
| Total Expenditure | 236 | 269 | 295 | 297 | 339 | 414 | 454 | 461 | 438 | 486 | 624 | 708 |
| Operating Profit | 41 | 47 | 46 | 46 | 64 | 80 | 116 | 123 | 92 | 86 | 103 | 128 |
| Interest | 1 | 2 | 3 | 5 | 6 | 4 | 5 | 5 | 7 | 9 | 9 | 9 |
| Depreciation | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 | 11 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 33 | 38 | 36 | 30 | 45 | 61 | 97 | 105 | 71 | 63 | 83 | 107 |
| Provision for Tax | 11 | 14 | 12 | 9 | 11 | 15 | 24 | 27 | 18 | 15 | 18 | 22 |
| Profit After Tax | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 65 | 83 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 65 | 83 |
| Adjusted Earnings Per Share | 1.4 | 1.6 | 1.6 | 1.4 | 2.2 | 3 | 4.8 | 5.1 | 3.5 | 3.2 | 4.3 | 5.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 28% | 7% | 8% | 10% |
| Operating Profit CAGR | 20% | -6% | 5% | 10% |
| PAT CAGR | 35% | -5% | 8% | 11% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 21% | 2% | 2% | 8% |
| ROE Average | 12% | 11% | 15% | 13% |
| ROCE Average | 14% | 14% | 19% | 17% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 200 | 224 | 238 | 252 | 275 | 310 | 369 | 430 | 470 | 506 | 559 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 16 | 11 | 8 | 5 | 8 | 5 | 3 | 2 |
| Other Non-Current Liabilities | 7 | 12 | 11 | 10 | 10 | 10 | 8 | 7 | 11 | 9 | 3 |
| Total Current Liabilities | 42 | 39 | 80 | 111 | 82 | 98 | 67 | 77 | 113 | 228 | 279 |
| Total Liabilities | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 522 | 598 | 747 | 843 |
| Fixed Assets | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 82 | 72 | 81 |
| Other Non-Current Assets | 3 | 10 | 50 | 7 | 6 | 4 | 4 | 3 | 6 | 12 | 6 |
| Total Current Assets | 189 | 208 | 224 | 283 | 272 | 333 | 362 | 441 | 511 | 663 | 757 |
| Total Assets | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 522 | 598 | 747 | 843 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 12 | 8 | 11 | 7 | 10 | 17 | 14 | 14 | 20 | 25 | 34 |
| Cash Flow from Operating Activities | 34 | 16 | 14 | -30 | 71 | 8 | 74 | 51 | 99 | -32 | 12 |
| Cash Flow from Investing Activities | -31 | -10 | -29 | 4 | -14 | -4 | -29 | -37 | -73 | -9 | 1 |
| Cash Flow from Financing Activities | -7 | -3 | 11 | 29 | -50 | -6 | -45 | -9 | -20 | 50 | -16 |
| Net Cash Inflow / Outflow | -4 | 3 | -4 | 3 | 7 | -3 | 0 | 6 | 5 | 8 | -3 |
| Closing Cash & Cash Equivalent | 8 | 11 | 7 | 10 | 17 | 14 | 14 | 20 | 25 | 34 | 31 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.42 | 1.61 | 1.59 | 1.37 | 2.23 | 2.97 | 4.78 | 5.08 | 3.5 | 3.17 | 4.26 |
| CEPS(Rs) | 1.83 | 2.07 | 2.06 | 2.08 | 3.13 | 3.97 | 5.73 | 5.96 | 4.41 | 4.08 | 5 |
| DPS(Rs) | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.7 | 1 | 1 | 0.8 | 0.7 | 0.8 |
| Book NAV/Share(Rs) | 13.16 | 14.72 | 15.65 | 16.52 | 18.05 | 20.37 | 24.22 | 28.26 | 30.83 | 33.25 | 36.73 |
| Core EBITDA Margin(%) | 14.2 | 13.48 | 9.93 | 12.3 | 14.4 | 14.65 | 18.8 | 20.66 | 15.25 | 12.98 | 12.42 |
| EBIT Margin(%) | 12.51 | 12.84 | 11.69 | 10.3 | 12.7 | 13.28 | 18.06 | 18.77 | 14.99 | 12.89 | 12.75 |
| Pre Tax Margin(%) | 12.04 | 12.32 | 10.91 | 8.8 | 11.3 | 12.45 | 17.24 | 17.86 | 13.65 | 11.2 | 11.47 |
| PAT Margin (%) | 7.88 | 7.84 | 7.37 | 6.15 | 8.58 | 9.31 | 12.99 | 13.22 | 10.24 | 8.56 | 8.99 |
| Cash Profit Margin (%) | 10.12 | 10.08 | 9.56 | 9.35 | 12.04 | 12.44 | 15.55 | 15.51 | 12.9 | 11.02 | 10.57 |
| ROA(%) | 8.9 | 9.32 | 8 | 5.8 | 8.87 | 11.28 | 16.66 | 15.95 | 9.52 | 7.17 | 8.15 |
| ROE(%) | 11.19 | 11.52 | 10.47 | 8.51 | 12.92 | 15.48 | 21.46 | 19.37 | 11.84 | 9.88 | 12.16 |
| ROCE(%) | 17.05 | 17.81 | 14.93 | 11.51 | 15.5 | 19.07 | 26.97 | 25.7 | 16.07 | 12.95 | 14.26 |
| Receivable days | 62.13 | 62.8 | 66.04 | 78.11 | 72.33 | 66.72 | 66.58 | 69.69 | 81.12 | 86.26 | 100.44 |
| Inventory Days | 108.92 | 97.85 | 104.11 | 127.93 | 122.59 | 107.6 | 113.1 | 123.26 | 151.87 | 166.77 | 155.52 |
| Payable days | 28.75 | 31.75 | 51.8 | 82.31 | 54.89 | 47.31 | 49.73 | 47.71 | 71.69 | 116.45 | 125.52 |
| PER(x) | 19.72 | 24.51 | 22.65 | 19.29 | 10.59 | 15.13 | 27.29 | 15.57 | 23.96 | 17.05 | 12.64 |
| Price/Book(x) | 2.13 | 2.67 | 2.3 | 1.6 | 1.31 | 2.21 | 5.39 | 2.8 | 2.72 | 1.62 | 1.46 |
| Dividend Yield(%) | 1.43 | 1.02 | 1.11 | 1.52 | 2.54 | 1.56 | 0.77 | 1.26 | 0.95 | 1.3 | 1.49 |
| EV/Net Sales(x) | 1.55 | 1.93 | 1.75 | 1.39 | 0.97 | 1.48 | 3.56 | 2.09 | 2.48 | 1.6 | 1.26 |
| EV/Core EBITDA(x) | 10.48 | 12.8 | 12.63 | 10.3 | 5.98 | 9.02 | 17.24 | 9.87 | 13.98 | 10.34 | 8.69 |
| Net Sales Growth(%) | 5.04 | 13.41 | 5.36 | 3.4 | 16.88 | 22.38 | 15.31 | 4.07 | -11.15 | 8.04 | 27.62 |
| EBIT Growth(%) | -22.52 | 16.51 | -4.18 | -8.92 | 44.08 | 28.21 | 56.86 | 8.51 | -28.99 | -6.93 | 26.52 |
| PAT Growth(%) | -18.04 | 13.05 | -0.99 | -13.9 | 63.13 | 33.2 | 60.85 | 6.24 | -31.15 | -9.5 | 34.38 |
| EPS Growth(%) | -18.04 | 13.05 | -0.98 | -13.9 | 63.13 | 33.2 | 60.85 | 6.24 | -31.15 | -9.5 | 34.38 |
| Debt/Equity(x) | 0.05 | 0.07 | 0.15 | 0.32 | 0.15 | 0.16 | 0.06 | 0.08 | 0.08 | 0.22 | 0.2 |
| Current Ratio(x) | 4.46 | 5.35 | 2.79 | 2.56 | 3.32 | 3.4 | 5.39 | 5.75 | 4.53 | 2.9 | 2.71 |
| Quick Ratio(x) | 2.71 | 2.94 | 1.62 | 1.26 | 1.83 | 1.72 | 2.66 | 2.98 | 2.57 | 1.62 | 1.56 |
| Interest Cover(x) | 26.66 | 24.83 | 15.13 | 6.87 | 9.06 | 16.11 | 21.93 | 20.52 | 11.21 | 7.65 | 9.96 |
| Total Debt/Mcap(x) | 0.02 | 0.03 | 0.07 | 0.2 | 0.12 | 0.07 | 0.01 | 0.03 | 0.03 | 0.13 | 0.14 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.15 | 0.05 | 0.06 | 0.06 | 0.09 | 0.07 | 0.06 | 0.04 | 0.03 | 0.04 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.11 | 0.23 | 0.23 | 0.02 | 0.02 |
| Public | 24.83 | 24.94 | 24.92 | 24.92 | 24.8 | 24.83 | 24.71 | 24.73 | 24.95 | 24.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 |
| FII | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
| DII | 0 | 0 | 0 | 0 | 0.02 | 0.02 | 0.04 | 0.04 | 0 | 0 |
| Public | 3.78 | 3.8 | 3.79 | 3.79 | 3.78 | 3.78 | 3.76 | 3.77 | 3.8 | 3.8 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +28% | +7% | +8% | +10% |
| Operating Profit CAGR | +20% | -6% | +5% | +10% |
| PAT CAGR | +35% | -5% | +8% | +11% |
| Share Price CAGR | +21% | +2% | +2% | +8% |
| ROE Average | +12% | +11% | +15% | +13% |
| ROCE Average | +14% | +14% | +19% | +17% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.15 | 0.05 | 0.06 | 0.06 | 0.09 | 0.07 | 0.06 | 0.04 | 0.03 | 0.04 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.11 | 0.23 | 0.23 | 0.02 | 0.02 |
| Public | 24.83 | 24.94 | 24.92 | 24.92 | 24.8 | 24.83 | 24.71 | 24.73 | 24.95 | 24.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 |
| FII | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
| DII | 0 | 0 | 0 | 0 | 0.02 | 0.02 | 0.04 | 0.04 | 0 | 0 |
| Public | 3.78 | 3.8 | 3.79 | 3.79 | 3.78 | 3.78 | 3.76 | 3.77 | 3.8 | 3.8 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.